Oral sumatriptan for the acute treatment of migraine: Evaluation of three dosage strengths

N. Cutler, G. R. Mushet, R. Davis, B. Clements, L. Whitcher, John L. Benedum, Milan L. Brandon, Neal Cutler, David Ginsberg, Claude B. Goswick, Andrew D. Grubbs, Frank W. Kilpatrick, John Claude Krusz, Hubert A. Leonard, Brain E. Mondell, James D. Mumper, George R. Mushet, Elson So

Research output: Contribution to journalArticle

85 Scopus citations

Abstract

This randomized, double–blind, parallel–group, placebo–controlled study evaluated the efficacy and tolerability of oral sumatriptan )Imitrex tablets( in 259 migraineurs. In the clinic, patients received oral sumatriptan 25 mg, 50 mg, or 100 mg, or placebo for the treatment of a migraine attack. The results indicate that by 2 hours post– dose, 50 to 56% of patients treated with any of the three doses, compared with 26% of patients treated with placebo, achieved relief of headache )p <; 0.05 for each sumatriptan group vs placebo(. By 4 hours postdose, 68 to 71% of suma– triptan–treated patients, compared with 38% of placebo–treated patients, achieved relief of headache )p < 0.05 for each sumatriptan group vs placebo(. Oral sumatriptan was similarly effective at relieving nausea and photophobia and at reducing clinical disability. The pattern and incidence of adverse events did not differ between treatment groups. All doses–25 mg, 50 mg, and 100 mg–of sumatriptan were effective and generally well tolerated. Dosing should be indi– vidualized according to the needs of the patient. NEUROLOGY 1995;45)suppl 7(:S5–S9

Original languageEnglish (US)
Pages (from-to)S5-S9
JournalNeurology
Volume45
Issue number8
StatePublished - Aug 1995

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Oral sumatriptan for the acute treatment of migraine: Evaluation of three dosage strengths'. Together they form a unique fingerprint.

  • Cite this

    Cutler, N., Mushet, G. R., Davis, R., Clements, B., Whitcher, L., Benedum, J. L., Brandon, M. L., Cutler, N., Ginsberg, D., Goswick, C. B., Grubbs, A. D., Kilpatrick, F. W., Krusz, J. C., Leonard, H. A., Mondell, B. E., Mumper, J. D., Mushet, G. R., & So, E. (1995). Oral sumatriptan for the acute treatment of migraine: Evaluation of three dosage strengths. Neurology, 45(8), S5-S9.